TABLE 1.

A list of pharmacokinetics, toxicity prediction and docking score of COMPs.

COMP	TPSA (Å2)	Protease inhibitory potential	LD50 (mg/kg)	Hepatotoxicity	Docking score (kcal/mol)
1	109.36	−0.19	4000	0.71 (inactive)	−13.6
2	120.36	−0.18	3850	0.65 (inactive)	−12.7
3	148.43	−0.27	4000	0.62 (inactive)	−12.7
4	127.45	0.07	2000	0.80 (inactive)	−12.6
5	111.13	−0.16	5000	0.73 (inactive)	−12.6
6	120.36	−0.12	5000	0.71 (inactive)	−12.5
7	90.90	−0.22	2430	0.69 (inactive)	−12.4
8	116.45	0.06	2000	0.77 (inactive)	−12.3
9	111.13	−0.07	2905	0.70 (inactive)	−12.2
10	162.88	0.33	4000	0.69 (inactive)	−12.1
11	89.13	−0.20	5000	0.73 (inactive)	−12.0
12	128.20	−0.23	1480	0.71 (inactive)	−12.0
13	120.36	0.04	2500	0.69 (inactive)	−11.9
14	127.45	0.03	2000	0.78 (inactive)	−11.8
15	127.45	0.04	2000	0.80 (inactive)	−11.8
quercetin	131.36	−0.25	159	0.69 (inactive)	−9.8